{
    "hands_on_practices": [
        {
            "introduction": "A hallmark of maternal adaptation to pregnancy is a dramatic increase in the glomerular filtration rate ($GFR$). However, accurately quantifying this change is challenging, as standard estimated $GFR$ equations are unreliable during gestation. This practice delves into a more rigorous method, using the principles of renal clearance and pharmacologic blockade to distinguish true glomerular filtration from the tubular secretion of creatinine, providing a more physiologically accurate assessment of renal function. ",
            "id": "4470795",
            "problem": "A gravida $1$, para $0$ patient at $22$ weeks of gestation is undergoing assessment of renal function in the context of the known pregnancy-associated increase in glomerular filtration rate (GFR). The laboratory provides simultaneous measurements of plasma creatinine and timed urine creatinine collections before and after pharmacologic blockade of tubular secretion. The following data are obtained under steady-state conditions:\n\n- Baseline $30$-minute urine collection: urine volume $36 \\ \\mathrm{mL}$, urinary creatinine concentration $72 \\ \\mathrm{mg/dL}$, plasma creatinine concentration $0.48 \\ \\mathrm{mg/dL}$.\n- Post-cimetidine $20$-minute urine collection (after intravenous cimetidine achieving a level known to block a constant fraction of proximal tubular secretion): urine volume $23 \\ \\mathrm{mL}$, urinary creatinine concentration $68.5 \\ \\mathrm{mg/dL}$, plasma creatinine concentration $0.48 \\ \\mathrm{mg/dL}$.\n- The fraction of tubular creatinine secretion blocked by cimetidine under these dosing conditions is $f = 0.80$.\n- Independently measured body surface area (BSA) is $1.84 \\ \\mathrm{m^2}$.\n\nUsing the mass conservation definition of renal clearance, the physiologic relation between excretion, filtration, and secretion for creatinine, and the effect of a fractional blockade of tubular secretion, derive and compute the best physiologically grounded estimate of the patient’s glomerular filtration rate normalized to $1.73 \\ \\mathrm{m^2}$. Round your answer to four significant figures. Express the final result in $\\mathrm{mL/min}$ per $1.73 \\ \\mathrm{m^2}$.\n\nFor clarity, define all quantities you use, including the distinction between measured creatinine clearance and true glomerular filtration rate (GFR). Also, briefly state why estimated glomerular filtration rate (eGFR) equations based solely on plasma creatinine concentration are limited in pregnancy. Do not use any shortcut formulas beyond fundamental definitions and well-tested physiologic relations.",
            "solution": "The problem is valid as it is scientifically grounded in established principles of renal physiology, well-posed with sufficient and consistent data, and objectively stated. It requires the application of fundamental definitions to derive a solution, which is a standard approach in quantitative science.\n\nThe solution requires determining the true glomerular filtration rate ($GFR$) by accounting for the tubular secretion of creatinine. The total urinary excretion rate of a substance is the sum of what is filtered by the glomerulus and what is secreted by the tubules, minus any reabsorption. For creatinine, reabsorption is negligible.\n\nLet's define the key physiological quantities:\n- $GFR$: Glomerular Filtration Rate, the volume of plasma filtered per unit time ($\\mathrm{mL/min}$).\n- $C_{Cr}$: Creatinine Clearance, the measured volume of plasma cleared of creatinine per unit time ($\\mathrm{mL/min}$).\n- $E_{Cr}$: The mass excretion rate of creatinine in urine ($\\mathrm{mg/min}$).\n- $TS_{Cr}$: The net rate of tubular secretion of creatinine into the urine ($\\mathrm{mg/min}$).\n- $P_{Cr}$: The plasma concentration of creatinine ($\\mathrm{mg/mL}$).\n- $U_{Cr}$: The urinary concentration of creatinine ($\\mathrm{mg/mL}$).\n- $\\dot{V}$: The urine flow rate ($\\mathrm{mL/min}$).\n\nThe fundamental relationship for creatinine handling by the kidney is:\n$$\n\\text{Excretion Rate} = \\text{Filtration Rate} + \\text{Secretion Rate}\n$$\nIn mathematical terms:\n$$\nE_{Cr} = (GFR \\times P_{Cr}) + TS_{Cr}\n$$\nThe excretion rate is measured from the urine collection data:\n$$\nE_{Cr} = U_{Cr} \\times \\dot{V}\n$$\nThe standard measured creatinine clearance ($C_{Cr}$) is defined as:\n$$\nC_{Cr} = \\frac{U_{Cr} \\times \\dot{V}}{P_{Cr}} = \\frac{E_{Cr}}{P_{Cr}}\n$$\nSubstituting the first equation into this definition reveals why $C_{Cr}$ overestimates the true $GFR$:\n$$\nC_{Cr} = \\frac{(GFR \\times P_{Cr}) + TS_{Cr}}{P_{Cr}} = GFR + \\frac{TS_{Cr}}{P_{Cr}}\n$$\nThe problem provides two sets of measurements, allowing us to solve for the two unknowns, $GFR$ and the baseline tubular secretion rate, which we will denote as $TS_{Cr,1}$. Let the subscript $1$ refer to the baseline condition and $2$ refer to the post-cimetidine condition. The plasma creatinine concentration $P_{Cr}$ is constant at $0.48 \\ \\mathrm{mg/dL}$ or $0.0048 \\ \\mathrm{mg/mL}$.\n\nFirst, we calculate the urinary excretion rates for both conditions.\n\nCondition 1 (Baseline):\n- Time $T_1 = 30 \\ \\mathrm{min}$\n- Urine volume $V_1 = 36 \\ \\mathrm{mL}$\n- Urine creatinine $U_{Cr,1} = 72 \\ \\mathrm{mg/dL} = 0.72 \\ \\mathrm{mg/mL}$\n- Urine flow rate $\\dot{V}_1 = \\frac{V_1}{T_1} = \\frac{36 \\ \\mathrm{mL}}{30 \\ \\mathrm{min}} = 1.2 \\ \\mathrm{mL/min}$\n- Excretion rate $E_{Cr,1} = U_{Cr,1} \\times \\dot{V}_1 = (0.72 \\ \\mathrm{mg/mL}) \\times (1.2 \\ \\mathrm{mL/min}) = 0.864 \\ \\mathrm{mg/min}$\n\nCondition 2 (Post-cimetidine):\n- Time $T_2 = 20 \\ \\mathrm{min}$\n- Urine volume $V_2 = 23 \\ \\mathrm{mL}$\n- Urine creatinine $U_{Cr,2} = 68.5 \\ \\mathrm{mg/dL} = 0.685 \\ \\mathrm{mg/mL}$\n- Urine flow rate $\\dot{V}_2 = \\frac{V_2}{T_2} = \\frac{23 \\ \\mathrm{mL}}{20 \\ \\mathrm{min}} = 1.15 \\ \\mathrm{mL/min}$\n- Excretion rate $E_{Cr,2} = U_{Cr,2} \\times \\dot{V}_2 = (0.685 \\ \\mathrm{mg/mL}) \\times (1.15 \\ \\mathrm{mL/min}) = 0.78775 \\ \\mathrm{mg/min}$\n\nNow, we can set up a system of two equations. Cimetidine blocks a fraction $f=0.80$ of the baseline tubular secretion, so the secretion rate in condition $2$ is $TS_{Cr,2} = (1-f) \\times TS_{Cr,1}$.\n\nEquation for Condition 1:\n$$\nE_{Cr,1} = (GFR \\times P_{Cr}) + TS_{Cr,1}\n$$\n\nEquation for Condition 2:\n$$\nE_{Cr,2} = (GFR \\times P_{Cr}) + TS_{Cr,2} = (GFR \\times P_{Cr}) + (1-f) \\times TS_{Cr,1}\n$$\n\nWe can solve this system for $GFR$. Subtracting the second equation from the first:\n$$\nE_{Cr,1} - E_{Cr,2} = ((GFR \\times P_{Cr}) + TS_{Cr,1}) - ((GFR \\times P_{Cr}) + (1-f) \\times TS_{Cr,1})\n$$\n$$\nE_{Cr,1} - E_{Cr,2} = TS_{Cr,1} - (1-f) \\times TS_{Cr,1} = f \\times TS_{Cr,1}\n$$\nThis allows us to find the baseline tubular secretion rate:\n$$\nTS_{Cr,1} = \\frac{E_{Cr,1} - E_{Cr,2}}{f}\n$$\nSubstituting this expression for $TS_{Cr,1}$ back into the first equation:\n$$\nE_{Cr,1} = (GFR \\times P_{Cr}) + \\frac{E_{Cr,1} - E_{Cr,2}}{f}\n$$\nNow, we solve for $GFR$:\n$$\nGFR \\times P_{Cr} = E_{Cr,1} - \\frac{E_{Cr,1} - E_{Cr,2}}{f} = \\frac{f \\cdot E_{Cr,1} - (E_{Cr,1} - E_{Cr,2})}{f} = \\frac{(f-1)E_{Cr,1} + E_{Cr,2}}{f}\n$$\n$$\nGFR = \\frac{(f-1)E_{Cr,1} + E_{Cr,2}}{f \\cdot P_{Cr}}\n$$\nPlugging in the given and calculated values:\n- $f = 0.80$\n- $E_{Cr,1} = 0.864 \\ \\mathrm{mg/min}$\n- $E_{Cr,2} = 0.78775 \\ \\mathrm{mg/min}$\n- $P_{Cr} = 0.0048 \\ \\mathrm{mg/mL}$\n$$\nGFR = \\frac{(0.80-1)(0.864) + 0.78775}{0.80 \\times 0.0048} = \\frac{(-0.20)(0.864) + 0.78775}{0.00384}\n$$\n$$\nGFR = \\frac{-0.1728 + 0.78775}{0.00384} = \\frac{0.61495}{0.00384} \\approx 160.1432 \\ \\mathrm{mL/min}\n$$\nThis is the patient's absolute $GFR$. It must be normalized to the standard body surface area ($BSA$) of $1.73 \\ \\mathrm{m^2}$. The patient's $BSA$ is $1.84 \\ \\mathrm{m^2}$.\n$$\nGFR_{normalized} = GFR \\times \\frac{1.73 \\ \\mathrm{m^2}}{BSA_{patient}}\n$$\n$$\nGFR_{normalized} = (160.1432 \\ \\mathrm{mL/min}) \\times \\frac{1.73}{1.84} \\approx 150.571 \\ \\mathrm{mL/min \\ per \\ 1.73 \\ m^2}\n$$\nRounding to four significant figures gives $150.6 \\ \\mathrm{mL/min}$ per $1.73 \\ \\mathrm{m^2}$.\n\nRegarding the limitations of estimated glomerular filtration rate (eGFR) equations (e.g., MDRD, CKD-EPI) in pregnancy: these equations are regression models derived from data in large, non-pregnant populations relating plasma creatinine concentration ($P_{Cr}$) to $GFR$ measured by a gold-standard method. They are inaccurate in pregnancy for several critical reasons:\n1.  **Altered Physiology**: Pregnancy induces profound physiological changes not present in the populations used to derive the equations. The $GFR$ increases by up to $50\\%$ (physiologic hyperfiltration), while plasma volume expansion causes hemodilution. These factors systematically lower $P_{Cr}$ for any given true $GFR$, breaking the relationship assumed by the eGFR formulas.\n2.  **Lack of Validation**: The equations were not developed or validated in pregnant cohorts. When applied to pregnant women, they consistently and significantly underestimate the measured $GFR$.\n3.  **Variable Creatinine Production and Secretion**: Changes in muscle mass and potentially altered tubular handling of creatinine during gestation add further variability not accounted for by the static eGFR equations.\nFor these reasons, direct measurement of clearance (ideally with a filtration marker like inulin, or more practically with a timed urine collection for creatinine clearance) is necessary for accurate assessment of renal function in pregnancy. The method used in this problem, which further refines the creatinine clearance by accounting for secretion, represents a highly rigorous approach.\nThe final computed value is the best estimate for the patient's normalized GFR.\n\n$$\nGFR_{normalized} \\approx 150.6 \\ \\mathrm{mL/min/1.73 \\ m^2}\n$$",
            "answer": "$$\n\\boxed{150.6}\n$$"
        },
        {
            "introduction": "The renal adaptations of pregnancy lead to significant plasma volume expansion and a consequent dilution of plasma proteins, which lowers plasma oncotic pressure. This exercise applies the fundamental Starling equation to model how these changes, combined with altered hydrostatic pressures, affect fluid balance at the microvascular level. By quantifying the transcapillary filtration rate, you will gain a deeper understanding of the physiological mechanisms that predispose pregnant individuals to dependent edema. ",
            "id": "4470814",
            "problem": "A primigravid patient at mid-gestation exhibits physiological hemodilution and reduced plasma oncotic pressure with mild dependent edema. Consider a representative microvascular segment in the maternal lower limb interstitium. Treat the plasma proteins as a single effective macromolecular species with molecular mass $M_{\\mathrm{eff}}$ and an effective reflection coefficient $\\sigma$. Assume the following:\n\n- Baseline (non-pregnant) plasma volume $V_0 = 3.0\\ \\mathrm{L}$, total plasma protein concentration $c_{\\mathrm{prot},0} = 7.0\\ \\mathrm{g/dL}$, and interstitial protein concentration $c_{\\mathrm{prot,i},0} = 2.0\\ \\mathrm{g/dL}$.\n- With pregnancy, plasma volume increases by $45$ percent so that $V_1 = 1.45\\,V_0$, and total circulating plasma protein mass decreases by $10$ percent so that $M_1 = 0.90\\,M_0$ where $M_0 = c_{\\mathrm{prot},0}\\,V_0$.\n- Baseline microvascular hydrostatic pressures are $P_{c,0} = 28\\ \\mathrm{mmHg}$ and $P_{i,0} = -2\\ \\mathrm{mmHg}$; in pregnancy they are $P_{c,1} = 31\\ \\mathrm{mmHg}$ and $P_{i,1} = 0\\ \\mathrm{mmHg}$.\n- The effective protein reflection coefficient changes from $\\sigma_0 = 0.90$ (baseline) to $\\sigma_1 = 0.80$ (pregnancy). The interstitial protein concentration in pregnancy increases to $c_{\\mathrm{prot,i},1} = 2.6\\ \\mathrm{g/dL}$.\n- The microvascular filtration coefficient (hydraulic conductance times surface area) changes from $K_{f,0} = 2.0 \\times 10^{-3}\\ \\mathrm{mL}\\,\\mathrm{min}^{-1}\\,\\mathrm{mmHg}^{-1}$ (baseline) to $K_{f,1} = 2.4 \\times 10^{-3}\\ \\mathrm{mL}\\,\\mathrm{min}^{-1}\\,\\mathrm{mmHg}^{-1}$ (pregnancy).\n- The macromolecular osmotic pressure obeys the van’t Hoff relation for an effectively impermeant solute of molecular mass $M_{\\mathrm{eff}} = 60{,}000\\ \\mathrm{g/mol}$ at absolute temperature $T = 310\\ \\mathrm{K}$, with gas constant $R = 62.364\\ \\mathrm{L}\\,\\mathrm{mmHg}\\,\\mathrm{mol}^{-1}\\,\\mathrm{K}^{-1}$.\n\nStarting from (i) conservation of mass for total plasma protein to obtain the pregnant plasma protein concentration, (ii) the van’t Hoff relation for the oncotic pressures in plasma and interstitium, and (iii) a linear constitutive relation that connects transcapillary volume flux to the net driving pressure (hydrostatic minus the oncotic term weighted by the reflection coefficient), derive the steady-state microvascular filtration rates $J_{v,0}$ (baseline) and $J_{v,1}$ (pregnancy). Then compute the increase in filtration rate $\\Delta J_v = J_{v,1} - J_{v,0}$. Round your final answer to three significant figures and express it in $\\mathrm{mL/min}$.",
            "solution": "The user-provided problem has been analyzed and is deemed to be valid. It is scientifically grounded in the principles of microvascular fluid dynamics (the Starling equation) and physical chemistry (the van't Hoff law for osmotic pressure). The problem is well-posed, providing all necessary parameters and a clear objective. The physiological values given are consistent with the changes observed during pregnancy. The problem is objective and free of ambiguities. Therefore, a full solution is presented below.\n\nThe transcapillary volume flux, $J_v$, is governed by the Starling equation:\n$$J_v = K_f \\left[ (P_c - P_i) - \\sigma (\\Pi_c - \\Pi_i) \\right]$$\nwhere $K_f$ is the microvascular filtration coefficient, $P_c$ and $P_i$ are the capillary and interstitial hydrostatic pressures, respectively, $\\Pi_c$ and $\\Pi_i$ are the capillary and interstitial oncotic pressures, respectively, and $\\sigma$ is the effective protein reflection coefficient.\n\nThe oncotic pressure, $\\Pi$, is determined by the concentration of plasma proteins, $c$, according to the van't Hoff relation:\n$$\\Pi = \\frac{c}{M_{\\mathrm{eff}}} RT$$\nwhere $M_{\\mathrm{eff}}$ is the effective molecular mass of the proteins, $R$ is the gas constant, and $T$ is the absolute temperature. For consistency in units, protein concentrations given in $\\mathrm{g/dL}$ must be converted to $\\mathrm{g/L}$ by multiplying by $10$.\n\nFirst, we calculate the constant factor that converts protein concentration (in $\\mathrm{g/L}$) to oncotic pressure (in $\\mathrm{mmHg}$):\n$$ \\frac{RT}{M_{\\mathrm{eff}}} = \\frac{(62.364\\ \\mathrm{L}\\,\\mathrm{mmHg}\\,\\mathrm{mol}^{-1}\\,\\mathrm{K}^{-1})(310\\ \\mathrm{K})}{60000\\ \\mathrm{g/mol}} = \\frac{19332.84}{60000}\\ \\mathrm{mmHg \\cdot L/g} = 0.322214\\ \\mathrm{mmHg / (g/L)} $$\n\nWe will now calculate the filtration rate for the baseline (non-pregnant) and pregnant states. Subscripts $0$ and $1$ will denote baseline and pregnancy, respectively.\n\n1.  **Baseline Filtration Rate ($J_{v,0}$)**\n\nThe given parameters are:\n-   $K_{f,0} = 2.0 \\times 10^{-3}\\ \\mathrm{mL}\\,\\mathrm{min}^{-1}\\,\\mathrm{mmHg}^{-1}$\n-   $P_{c,0} = 28\\ \\mathrm{mmHg}$\n-   $P_{i,0} = -2\\ \\mathrm{mmHg}$\n-   $\\sigma_0 = 0.90$\n-   $c_{\\mathrm{prot},0} = 7.0\\ \\mathrm{g/dL} = 70\\ \\mathrm{g/L}$\n-   $c_{\\mathrm{prot,i},0} = 2.0\\ \\mathrm{g/dL} = 20\\ \\mathrm{g/L}$\n\nThe net hydrostatic pressure is:\n$$ \\Delta P_0 = P_{c,0} - P_{i,0} = 28\\ \\mathrm{mmHg} - (-2\\ \\mathrm{mmHg}) = 30\\ \\mathrm{mmHg} $$\nThe net oncotic pressure is:\n$$ \\Delta \\Pi_0 = \\Pi_{c,0} - \\Pi_{i,0} = \\frac{RT}{M_{\\mathrm{eff}}} (c_{\\mathrm{prot},0} - c_{\\mathrm{prot,i},0}) = (0.322214\\ \\mathrm{mmHg/(g/L)}) (70\\ \\mathrm{g/L} - 20\\ \\mathrm{g/L}) = 16.1107\\ \\mathrm{mmHg} $$\nThe total net driving pressure for filtration is:\n$$ P_{\\mathrm{net},0} = \\Delta P_0 - \\sigma_0 \\Delta \\Pi_0 = 30\\ \\mathrm{mmHg} - (0.90)(16.1107\\ \\mathrm{mmHg}) = 30\\ \\mathrm{mmHg} - 14.49963\\ \\mathrm{mmHg} = 15.50037\\ \\mathrm{mmHg} $$\nThe baseline filtration rate is:\n$$ J_{v,0} = K_{f,0} \\cdot P_{\\mathrm{net},0} = (2.0 \\times 10^{-3}\\ \\mathrm{mL}\\,\\mathrm{min}^{-1}\\,\\mathrm{mmHg}^{-1}) (15.50037\\ \\mathrm{mmHg}) = 0.03100074\\ \\mathrm{mL/min} $$\n\n2.  **Pregnancy Filtration Rate ($J_{v,1}$)**\n\nFirst, we determine the plasma protein concentration during pregnancy, $c_{\\mathrm{prot},1}$.\n-   Baseline plasma volume: $V_0 = 3.0\\ \\mathrm{L}$\n-   Baseline total protein mass: $M_0 = c_{\\mathrm{prot},0} V_0 = (70\\ \\mathrm{g/L})(3.0\\ \\mathrm{L}) = 210\\ \\mathrm{g}$\n-   Pregnancy plasma volume: $V_1 = 1.45 V_0 = 1.45(3.0\\ \\mathrm{L}) = 4.35\\ \\mathrm{L}$\n-   Pregnancy total protein mass: $M_1 = 0.90 M_0 = 0.90(210\\ \\mathrm{g}) = 189\\ \\mathrm{g}$\n-   Pregnancy plasma protein concentration: $c_{\\mathrm{prot},1} = \\frac{M_1}{V_1} = \\frac{189\\ \\mathrm{g}}{4.35\\ \\mathrm{L}}$\n\nNow, we use the given parameters for pregnancy:\n-   $K_{f,1} = 2.4 \\times 10^{-3}\\ \\mathrm{mL}\\,\\mathrm{min}^{-1}\\,\\mathrm{mmHg}^{-1}$\n-   $P_{c,1} = 31\\ \\mathrm{mmHg}$\n-   $P_{i,1} = 0\\ \\mathrm{mmHg}$\n-   $\\sigma_1 = 0.80$\n-   $c_{\\mathrm{prot,i},1} = 2.6\\ \\mathrm{g/dL} = 26\\ \\mathrm{g/L}$\n\nThe net hydrostatic pressure is:\n$$ \\Delta P_1 = P_{c,1} - P_{i,1} = 31\\ \\mathrm{mmHg} - 0\\ \\mathrm{mmHg} = 31\\ \\mathrm{mmHg} $$\nThe net oncotic pressure is:\n$$ \\Delta \\Pi_1 = \\Pi_{c,1} - \\Pi_{i,1} = \\frac{RT}{M_{\\mathrm{eff}}} (c_{\\mathrm{prot},1} - c_{\\mathrm{prot,i},1}) = (0.322214\\ \\mathrm{mmHg/(g/L)}) \\left( \\frac{189}{4.35} - 26 \\right) \\mathrm{g/L} $$\n$$ \\Delta \\Pi_1 = (0.322214) \\left( \\frac{189 - 26 \\times 4.35}{4.35} \\right) = (0.322214) \\left( \\frac{189 - 113.1}{4.35} \\right) = (0.322214) \\left( \\frac{75.9}{4.35} \\right) \\approx 5.624036\\ \\mathrm{mmHg} $$\nThe total net driving pressure for filtration is:\n$$ P_{\\mathrm{net},1} = \\Delta P_1 - \\sigma_1 \\Delta \\Pi_1 = 31\\ \\mathrm{mmHg} - (0.80)(5.624036\\ \\mathrm{mmHg}) = 31\\ \\mathrm{mmHg} - 4.4992288\\ \\mathrm{mmHg} = 26.5007712\\ \\mathrm{mmHg} $$\nThe pregnancy filtration rate is:\n$$ J_{v,1} = K_{f,1} \\cdot P_{\\mathrm{net},1} = (2.4 \\times 10^{-3}\\ \\mathrm{mL}\\,\\mathrm{min}^{-1}\\,\\mathrm{mmHg}^{-1}) (26.5007712\\ \\mathrm{mmHg}) = 0.06360185\\ \\mathrm{mL/min} $$\n\n3.  **Increase in Filtration Rate ($\\Delta J_v$)**\n\nThe increase in filtration rate is the difference between the pregnancy and baseline rates:\n$$ \\Delta J_v = J_{v,1} - J_{v,0} = 0.06360185\\ \\mathrm{mL/min} - 0.03100074\\ \\mathrm{mL/min} = 0.03260111\\ \\mathrm{mL/min} $$\nRounding the result to three significant figures, we get $0.0326\\ \\mathrm{mL/min}$.",
            "answer": "$$\\boxed{0.0326}$$"
        },
        {
            "introduction": "Changes in renal function not only represent physiological adaptation but can also serve as crucial indicators of pathology, such as preeclampsia. This problem integrates renal physiology with clinical decision-making by examining the handling of uric acid, a key biomarker. You will first calculate the expected serum uric acid level based on changes in $GFR$ and tubular function, and then use this result in a Bayesian framework to determine the posterior probability of disease, illustrating how quantitative physiological reasoning enhances diagnostic assessment. ",
            "id": "4470781",
            "problem": "A gravida at $34$ weeks of gestation exhibits physiologic and pathophysiologic changes in renal handling of uric acid. Assume the following are true and constant for this individual: the whole-body uric acid production rate is $R = 1.35$ mg/min; uric acid is freely filtered at the glomerulus; and at steady state, the serum uric acid concentration is determined by the balance between production and renal excretion. In early normal pregnancy, the glomerular filtration rate (GFR) is $180$ mL/min and the fractional excretion of uric acid (FEUA) is $0.25$. At $34$ weeks, due to developing hypertensive disease, the GFR is $120$ mL/min and FEUA is $0.15$.\n\nA clinical decision rule uses a serum uric acid threshold of $5.5$ mg/dL to classify the test as positive for predicting preeclampsia. The test parameters at this threshold are sensitivity $0.78$ and specificity $0.88$. The patient’s pre-test probability of preeclampsia based on clinical risk factors is $0.25$.\n\nUsing only first-principles definitions of renal clearance and probabilistic inference, and assuming steady state for uric acid, determine the patient’s posterior probability of preeclampsia at $34$ weeks given the above renal handling and the decision rule threshold. Express the final posterior probability as a decimal number. Round your final answer to four significant figures.",
            "solution": "The fundamental physiological base is the steady-state mass balance and the definition of renal clearance. At steady state, the rate of production of a solute equals its rate of excretion. For a solute that is freely filtered and subject to net tubular handling summarized by the fractional excretion, the renal clearance is the product of the glomerular filtration rate (GFR) and the fractional excretion. The key definitions are:\n\n- Renal clearance of uric acid, $C_{\\mathrm{UA}}$, is given by the product of glomerular filtration rate and fractional excretion of uric acid: \n$$\nC_{\\mathrm{UA}} = \\mathrm{GFR} \\times \\mathrm{FEUA}.\n$$\n\n- Steady-state balance for serum uric acid concentration, $P_{\\mathrm{UA}}$, given a constant production rate $R$ and clearance $C_{\\mathrm{UA}}$, satisfies:\n$$\nR = C_{\\mathrm{UA}} \\times P_{\\mathrm{UA}}.\n$$\nHence,\n$$\nP_{\\mathrm{UA}} = \\frac{R}{C_{\\mathrm{UA}}}.\n$$\n\nWe first compute the serum uric acid concentration at $34$ weeks using the provided renal parameters. The late pregnancy values are $\\mathrm{GFR} = 120$ mL/min and $\\mathrm{FEUA} = 0.15$. Therefore,\n$$\nC_{\\mathrm{UA,34w}} = 120 \\times 0.15 = 18 \\ \\text{mL/min}.\n$$\nWith $R = 1.35$ mg/min,\n$$\nP_{\\mathrm{UA,34w}} = \\frac{1.35}{18} = 0.075 \\ \\text{mg/mL}.\n$$\nTo express in mg/dL, note that $1$ dL $= 100$ mL, so:\n$$\nP_{\\mathrm{UA,34w}} = 0.075 \\times 100 = 7.5 \\ \\text{mg/dL}.\n$$\n\nThe decision rule classifies the test as positive if the serum uric acid is at least $5.5$ mg/dL. Since $7.5$ mg/dL $\\geq 5.5$ mg/dL, the test is positive.\n\nWe now compute the posterior probability of preeclampsia using probabilistic inference. The fundamental base is Bayes’ theorem, which can be conveniently expressed in odds form for diagnostic testing:\n\n- Define sensitivity $S$ and specificity $T$:\n$$\nS = 0.78, \\quad T = 0.88.\n$$\n- The positive likelihood ratio is:\n$$\n\\mathrm{LR}^{+} = \\frac{S}{1 - T} = \\frac{0.78}{1 - 0.88} = \\frac{0.78}{0.12} = 6.5.\n$$\n- Convert the pre-test probability $p_{0} = 0.25$ to pre-test odds:\n$$\no_{0} = \\frac{p_{0}}{1 - p_{0}} = \\frac{0.25}{0.75} = \\frac{1}{3} \\approx 0.333333\\ldots.\n$$\n- The posterior odds after a positive test are:\n$$\no_{1} = o_{0} \\times \\mathrm{LR}^{+} = \\frac{1}{3} \\times 6.5 = \\frac{6.5}{3} \\approx 2.166666\\ldots.\n$$\n- Convert posterior odds to posterior probability:\n$$\np_{1} = \\frac{o_{1}}{1 + o_{1}} = \\frac{2.166666\\ldots}{1 + 2.166666\\ldots} = \\frac{2.166666\\ldots}{3.166666\\ldots}.\n$$\nCompute the quotient:\n$$\np_{1} \\approx 0.6842105263\\ldots.\n$$\n\nRounded to four significant figures, the posterior probability is:\n$$\n0.6842.\n$$\n\nThis is the requested decimal posterior probability under the given renal handling and decision rule threshold.",
            "answer": "$$\\boxed{0.6842}$$"
        }
    ]
}